DruSO-CU

This international project aims to calculate the drug survival of omalizumab in a large multicenter daily practice cohort of patients with CU treated in UCARE centers, and identify determinants of drug survival in this overall international population differentiated by reason of discontinuation.

Contact: H.Rockmann@umcutrecht.nl

News

UCARE Session and Workshop on March 13th, 2020 during the 5th Indercos Congress in Istanbul, Turkey

Dr. Kemal Özyurt is inviting UCARE members to participate in a UCARE Session and Workshop which will be held on March 13th, 2020 during the 5th Indercos Congress in Istanbul, Turkey.

For more information, please visit: www.indercos.org/images/UCARE.jpg

Read more

First Preceptorship in Beijing

Our first preceptorship was very successful, with 20+ participants from all over China joining us on 18th October 2019 for a full day masterclass with lectures, case reports, interactive discussion sessions, workshops, and a knowledge test.

Read more

UCARE Urticaria Conference 2019 - Istanbul

It is a great pleasure to invite you to the 2019 UCARE URTICARIA CONFERENCE, which will be held in the city of two continents, the city of the past, the present and the future, ISTANBUL. This year’s meeting is all about SHARING BEST PRACTICE IN URTICARIA. Let’s discuss our experience, share our expertise and harmonize our approach to the management of urticaria.

Read more

Contact us

GA²LEN coordinating Office
Charité Universitätsmedizin Berlin
Luisenstr. 2-5
10117 Berlin, Germany

UCARE office
Laura Schwenner

info(at)ga2len-ucare.com